| scholarly article | Q13442814 |
| P2093 | author name string | Beate Lanske | |
| M Shawkat Razzaque | |||
| Mutsuko Ohnishi | |||
| Teruyo Nakatani | |||
| P2860 | cites work | Mutation of the mouse klotho gene leads to a syndrome resembling ageing | Q24328782 |
| The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis | Q24625902 | ||
| FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player? | Q24653541 | ||
| Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system | Q28207490 | ||
| Vascular calcification: pathobiology of a multifaceted disease | Q28282418 | ||
| Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization | Q28283679 | ||
| Genetic evidence of serum phosphate-independent functions of FGF-23 on bone | Q28473286 | ||
| Conditional deletion of Indian hedgehog from collagen type 2alpha1-expressing cells results in abnormal endochondral bone formation | Q28512793 | ||
| Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis | Q28570122 | ||
| Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities | Q28587985 | ||
| Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase | Q35126790 | ||
| Molecular, endocrine, and genetic mechanisms of arterial calcification | Q35856234 | ||
| Regulation of phosphorus homeostasis by the type iia na/phosphate cotransporter | Q36191092 | ||
| Hypophosphatemia: an update on its etiology and treatment | Q36272304 | ||
| New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter. | Q36905432 | ||
| Can fibroblast growth factor 23 fine-tune therapies for diseases of abnormal mineral ion metabolism? | Q36966608 | ||
| alpha-Klotho: a regulator that integrates calcium homeostasis | Q37045462 | ||
| In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis | Q37072412 | ||
| Does Fgf23-klotho activity influence vascular and soft tissue calcification through regulating mineral ion metabolism? | Q37182735 | ||
| Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model | Q37415834 | ||
| The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel | Q40359636 | ||
| Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process | Q42736434 | ||
| Does FGF23 toxicity influence the outcome of chronic kidney disease? | Q43078080 | ||
| Mineral metabolism, mortality, and morbidity in maintenance hemodialysis | Q50144395 | ||
| Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice | Q56767950 | ||
| Collagen-binding heat shock protein (HSP) 47 expression in anti-thymocyte serum (ATS)-induced glomerulonephritis. | Q64999385 | ||
| Immunolocalization of collagen and collagen-binding heat shock protein 47 in fibrotic lung diseases | Q77747025 | ||
| Life-long suppression of growth hormone-insulin-like growth factor I activity in genetically altered rats could prevent age-related renal damage | Q80228977 | ||
| FGF-23, vitamin D and calcification: the unholy triad | Q80394650 | ||
| Genetic suppression of GH-IGF-1 activity, combined with lifelong caloric restriction, prevents age-related renal damage and prolongs the life span in rats | Q81147498 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 583-590 | |
| P577 | publication date | 2009-09-21 | |
| P1433 | published in | Circulation: Cardiovascular Genetics | Q15816430 |
| P1476 | title | In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels | |
| P478 | volume | 2 |
| Q42727584 | A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease |
| Q37062520 | Accelerated ageing and renal dysfunction links lower socioeconomic status and dietary phosphate intake |
| Q37244863 | Can features of phosphate toxicity appear in normophosphatemia? |
| Q37498019 | Can salivary phosphate levels be an early biomarker to monitor the evolvement of obesity? |
| Q37853829 | Cell biological and physicochemical aspects of arterial calcification |
| Q35003219 | Dietary and genetic evidence for enhancing glucose metabolism and reducing obesity by inhibiting klotho functions |
| Q34072221 | Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging |
| Q88797838 | Discovery of Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Cotransporter NaPi2a (SLC34A1) |
| Q37801814 | Disorders of phosphorus homeostasis |
| Q35550601 | Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD. |
| Q34788510 | Genetic ablation of sfrp4 in mice does not affect serum phosphate homeostasis. |
| Q36992835 | Genetic induction of phosphate toxicity significantly reduces the survival of hypercholesterolemic obese mice |
| Q34985917 | Heat shock protein 47: a novel biomarker of phenotypically altered collagen-producing cells |
| Q37171561 | High levels of serum vitamin D are associated with a decreased risk of metabolic diseases in both men and women, but an increased risk for coronary artery calcification in Korean men. |
| Q90721090 | In Vivo Toxicity and In Vitro Solubility Assessment of Pre-Treated Struvite as A Potential Alternative Phosphorus Source in Animal Feed |
| Q28535055 | Inadequate awareness among chronic kidney disease patients regarding food and drinks containing artificially added phosphate |
| Q34457281 | Klotho deficiency causes vascular calcification in chronic kidney disease |
| Q37606037 | Klotho deficiency disrupts hematopoietic stem cell development and erythropoiesis |
| Q38115124 | Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism |
| Q64231913 | Lack of Awareness of Dietary Sources of Phosphorus Is a Clinical Concern |
| Q34119083 | Lack of awareness among future medical professionals about the risk of consuming hidden phosphate-containing processed food and drinks |
| Q39102539 | Membrane ion Channels and Receptors in Animal lifespan Modulation. |
| Q90040434 | Modifying Phosphate Toxicity in Chronic Kidney Disease |
| Q35441666 | Molecular basis of Klotho: from gene to function in aging |
| Q35059924 | Molecular regulation of phosphate metabolism by fibroblast growth factor-23-klotho system |
| Q35059741 | Osteo-renal regulation of systemic phosphate metabolism |
| Q35417067 | PTH ablation ameliorates the anomalies of Fgf23-deficient mice by suppressing the elevated vitamin D and calcium levels |
| Q35546322 | Phosphate Metabolism in Cardiorenal Metabolic Disease |
| Q35679883 | Phosphate and Klotho |
| Q35059905 | Phosphate toxicity: new insights into an old problem |
| Q57594641 | Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release |
| Q35318410 | Role of Klotho in aging, phosphate metabolism, and CKD. |
| Q89568424 | Role of sodium-dependent Pi transporter/Npt2c on Pi homeostasis in klotho knockout mice different properties between juvenile and adult stages |
| Q38745657 | Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort |
| Q53357907 | Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification. |
| Q39006777 | The FGF23 and Klotho system beyond mineral metabolism. |
| Q93222971 | The Klotho proteins in health and disease |
| Q36280036 | The Role and Mechanism of α-Klotho in the Calcification of Rat Aortic Vascular Smooth Muscle Cells |
| Q35059753 | The dualistic role of vitamin D in vascular calcifications |
| Q36992839 | The role of Klotho in energy metabolism |
| Q42529430 | Therapeutic potential of klotho-FGF23 fusion polypeptides: WO2009095372 |
| Q38633152 | Vitamin D, phosphate, and vasculotoxicity. |
Search more.